FindTrial
Sign In

Investigation of menstrual bleeding characteristics after SARS-CoV-2 infection

Investigation of menstrual bleeding characteristics after SARS-CoV-2 infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069491
Enrollment
Unknown
Registered
2023-03-19
Start date
2023-03-20
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

emmeniopathy

Interventions

Investigation Group:N/A

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Female, over 18 years old residing in China; 2. Patients infected with SARS-CoV-2.

Exclusion criteria

Exclusion criteria: 1. Not able to read and understand Chinese; 2. Currently pregnant or lactating; 3. Menopause or Amenorrhea.

Design outcomes

Primary

MeasureTime frame
menstrual characteristics;—

Secondary

MeasureTime frame
Covid-19 symptoms and treatments;—

Countries

China

Contacts

Public ContactHuang Yuhua

Beijing Hospital of Traditional Chinese Medicine

hyuhua@163.com+86 13661198679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026